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The spread of COVID-19 across the world in 2020 heralded public health
restrictions on economic and social life that were in many countries amongst
the most stringent ever seen in peacetime. With varying restrictions still in
place at the time of writing across countries, the full extent of the impact of
these restrictions on economic outcomes is still playing out. Early indicators
show substantial reductions in economic activity in line with the intensity
of public health measures (Apedo Amah et al., 2020; Bartlett & Morse, 2020;
Chetty et al., 2020).
Theses measures have impacted the level and distribution of economic
activity in a multitude of ways. In terms of the impact on enterprises,
much of the existing literature has focused on the impact on turnover and
employment as well as the efficacy of the policy response (Apedo Amah
et al., 2020; Cirera et al., 2020; Bartik et al., 2020a,b). However, a critical
issue that is absent from the literature (as far as we are aware) is research on
what investments firms made in mitigation measures or other public health-
related expenditures to attempt to continue to operate safely. Given these
investments (such as in premises changes, personal protective equipment
and staff separation devises) were likely to be an important consideration
for firms, it is useful to understand their size, determinants, financing and
the heterogeneity of deployment across firms.
To address this gap in the literature around the impact of COVID-19, we
examine how much small and medium enterprises (SMEs) in Ireland spent
on compliance with social distancing and other public health measures and
how these expenditures were financed. Ireland is a useful case study as it
had some of the most stringent public health measures in the first lockdown
phase from April to June 2020. This gives us an insight into the operational
adjustment costs that firms faced as a result of the pandemic and how these
varied across firm characteristics. To explore these issues, we use a novel
survey collected by the Irish Ministry of Finance in late 2020. This provides
information to quantify the impact of the pandemic on health compliance
costs. A general overview of the survey can be found in Kren et al. (2021)
which provides a detailed analysis of the broader impact on firms.
We find that almost all firms (86 per cent) incurred some level of expense
to comply with the new health requirements, the mean expenditure was
=C15,595 with a median spend of =C3,500. The main exception was amongst
the self-employed who were less likely to invest in this area. In terms
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of the level of expenditure, we find that the amount spent was mostly
proportional to the number of employees. There were however differences
across sectors (primarily contrasting consumer-oriented sectors with those
less reliant on face-to-face transactions.) The investments were relatively
small for most firms and almost entirely financed by existing internal funds
(despite the pressures of COVID-19-related turnover reductions). Somewhat
surprisingly, we find little correlation between these expenditures and
traditional determinants of investment expenditure (such as profitability,
access to finance, indebtedness etc). The lack of a correlation between firm
performance and investment expenditures shows the unique nature of the
shock and the randomness of its impact across enterprises.
The remainder of the paper is structured as follows. Section 2 presents
the data and descriptive statistics. Section 3 outlines the regression analysis
while section 4 concludes.
2 Data and descriptive statistics
Our data are taken from a bespoke survey module that was conducted in
October 2020 as part of a long running SME Credit Demand Survey series,
undertaken by the Irish Ministry of Finance. This survey has been used by a
number of researchers to assess the impact of various financial and other
factors on SME investment activity (Gerlach-Kristen et al., 2015; Lawless
et al., 2015; Martinez-Cillero et al., 2020). A full overview of this module,
which was designed to capture the impact of the COVID-19 pandemic on
Irish SMEs, can be found in Kren et al. (2021). In this module, we asked
firms the following question:
"To deal with changes to the business environment around COVID-19,
have you invested in your business with a view to changing your
operation in line with public health guidelines e.g. adaptions for
physical distancing, hand hygiene etc?"
If firms answered yes to this question, they were then asked how much
in euros they spent and how it was financed (e.g. internal funds, external
finance from banks, trade credit, equity and other financing).
Figure 2 plots the overall distribution of investments in health expendit-
ures across all firms in the survey. There is a notable spike at zero expenditure,
with 14% of SMEs reporting no outlays in this area. The median investment
amount (indicated by the dashed line in the graph) is approximately =C3,500.
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The distribution is fairly skewed with the mean investment more than four
times the median at =C15,595 (the solid vertical line).
This leads us to ask howmuch the extensive (participation in expenditure)
and intensive (spending amounts)margins vary by observable characteristics
such as sector of activity and firm size. Might these be enough to understand
the observedmass at zero and degree of skewness evident in the presentation
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Figure 1: Kernel density estimation of total health-measure investments
Median = =C3,500 (dashed line), mean = =C15,595 (solid line). 14% of SMEs do not report any
COVID-19 related public health investments.
Looking first at firm size as a driver of investment in complying with
healthmeasures, Figure 2 plots the probability of having invested any amount
by number of employees and Figure 3 plots the amount. There is a strong
positive relationship between firm size and the probability of investing,
particularly at the lower end of the size distribution. This flattens off for
firms with over ten employees with the probability of investing approaching
one at that point. While firm size therefore plays a role in undertaking these
investments, we find that the amount spent varies little per employee so
although larger firms will have spent more overall, there is no real evidence
of scale changing the per-employee cost.
Figure 3 shows the close fit of the mean and median expenditures per
employee, both including and excluding those with zero expenditure. For
the smallest firms, particularly those with fewer than five employees, there
is an initial substantial gap between the expenditures depending on whether
zero values are included. However, as the participation rate increases sharply
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Figure 2: Probability of health measure investments as function of firm size
Shaded area is 95% confidence band.
We next split the survey sample into twelve sectors to give as great
a degree of granularity as possible while maintaining adequately robust
sample sizes. We also look at four size classifications for the firms: these are
self-employed, other micro firms (employ between 2 and 9 people), small
firms (10 to 49 employees) and medium firms (50 to 249 employees). Table
1 compares the distribution of health investments across these sectors and
size classes, with the extent of the turnover shock from the pandemic for
each group also presented for context. The first two columns give some
background statistics on the groups: the first column reports the number
of firms in each group out of the total of 1,503 firms in the survey; and the
second column reports the average employment which shows a fair degree
of variation across sectors.
For the health compliance investments, Table 1 first reports the share
of firms that reported having positive expenditures in this area. It then
reports the mean and median of expenditure scaled by the number of
employees (health expenditures per employee). More detailed graphing of
the full distributions of these investments by sector and size are presented
in Appendix. Likewise, the extent of the turnover shock (in euros per
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Figure 3: Value of health measure investments by firm size
Means conditional on size are estimated using kernel-weighted local polynomial smoothing.
Conditional medians estimated using median spline. Blue lines include all firms in the
sample, red lines exclude firms without COVID-19-related health measure investments.
Shaded area is 95% confidence band.
above, the vast majority of firms (86%) spent some amount on compliance
with health measures with a small but non-negligible group of 14% having
no expenditure in this area.
The most evident variation in the participation margin is by firm size
group. Almost all small and medium firms had some expenditure to comply
with the new health restrictions. This falls to 79% for small firms and just
half for the self-employed. Ability to work remotely and lower necessity
for face-to-face contact amongst the smallest firms is likely to play a role
in explaining this pattern across size groups. Once investment was being
made, however, the variation in the level of expenditures seems relatively
modest when expressed as an amount per employee. The mean expenditure
by the self-employed andmicro firms are rather lower than that of firms with
more employees but there is very little difference in expenditures between
small and medium sized firms. Across sectors, the highest expenditures are
in human health, construction and hotels and restaurants. Administrative
and professional services report the lowest average spending levels as well
as both being at the lower end of the participation range. This is likely to
reflect greater ease of remote working within these two sectors. This is an
important finding as it shows the uneven cost on a sectoral level and is likely
to have policy implications. For example, sectoral supports are likely to
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be more effective and desirable (in terms of targeting impacted firms) than
blanket instruments.
The right-hand panel of Table 1 shows the reductions in turnover per
employee across the broad sectors and size groups. The figures in the table
contrast the period between mid-March and October 2020 to the level of
activity in 2019. Considerable variation is evident both across and within
groups. Using this survey, Kren et al. (2021) find a mean overall fall in
turnover of over 26 per cent for all SMEs, with turnover halving for firms at
the 25th percentile. As shown in this table, firms at the 75th percentile faced
no reduction in turnover in many sectors. The exceptions are in hotels and
restaurants, motor trade and transport, where even the better performing
firms made losses. In contrast, the top quartile of firms in the retail sector
increased turnover.
Table 1: Health measure investments in EUR per employee and size of
COVID-19 turnover shock
H. investments Δ Turnover
Freq. Empl. % Mean Median Mean Median
Agriculture & food 59 24.7 78 471 222 -2,195 -236
Manufacturing 151 35.2 86 482 250 -2,626 -2,042
Construction 136 21.4 84 606 286 -3,360 -2,083
Wholesale 182 27.3 86 370 208 -4,858 -2,875
Retail trade 236 19.3 86 454 214 -1,501 -938
Motor trade & repair 52 16.0 97 470 250 -6,798 -5,515
Hotels & restaurants 167 51.6 94 605 222 -3,207 -2,083
Transport 61 41.0 90 405 250 -2,927 -2,398
Real estate & finance 64 30.5 93 474 278 -1,090 0
Professional serv. 226 23.7 76 373 154 -2,827 -1,146
Administrative serv. 90 52.0 84 300 111 -2,550 -868
Human health 77 37.5 95 894 444 -1,049 -500
Self-empl 157 1.0 50 386 0 -2,672 -1,250
Micro 429 4.7 79 430 200 -3,069 -1,458
Small 571 20.9 94 521 286 -3,082 -1,786
Medium 346 92.6 98 511 208 -2,417 -972
Total 1503 30.7 86 478 226 -2,879 -1478
Empl. = mean number of full-time equivalent employees. % = Percentage of firms who had
invested into health compliance measures. Turnover shock in EUR per employee per month.
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Faced with a new expense at the same time as a substantial reduction
in turnover for many firms, an obvious question is how was this financed?
Table 2 shows that, despite the environment of economic stress, the vast
majority of firms financed the investments from existing internal resources.
For the self-employed, we find that the resources of the firm and the owner
are more intermingled with the owner supplementing the internal resources
of the firm. This was occasionally reported for firms with employees but
with a much lower incidence. External sources of funding played a minor
role across all firm size groups. This is in line with the findings of Gargan
et al. (2018) who reported on pre-COVID investment decisions of SMEs were
strongly linked to availability of internal financing.
Table 2: Financing sources of health measure investments
Size category
Self-empl Micro Small Medium Total
Internal financing 80.4 85.9 86.2 91.4 87.1
Owner’s contribution 15.3 5.7 2.1 1.2 3.6
Supplier credit 0.0 0.3 1.0 0.9 0.7
Bank loans 0.4 0.2 0.8 1.1 0.7
External equity 0.0 0.3 0.5 1.2 0.6
Leasing or hire purchase 0.0 0.2 0.2 0.0 0.1
Other 1.8 6.2 7.4 3.8 5.8
No answer 0.0 0.5 0.5 0.0 0.4
3 Regression analysis
In this section, we explore in more depth if the observed level of investment
in health compliance measures vary in any systematic way with firm charac-
teristics. We have already noted some variation across sectors and enterprise
size (self-employed versus rest) in the descriptive statistics and now check if
these are robust to the inclusion of other factors in a multivariate setting. To
control for scale, we use investment per employee as our dependent variable
and use a tobit regression specification to reflect the zero values associated


































where  is the expenditure on health investments by firm 8, and  is the
number of employees. The error term &8 is distributed i.i.d. normal. The
vector of explanatory variables -8 contains the main variables. In this vector,
along with controls for sector and size described above, we include a number
of other potential drivers of investment. We include a range of characteristics
available in the survey that the literature on SME investment decisions would
suggest may be important such as profitability, firm performance etc. These
indicators are motivated by the traditional models linking investment to
marginal product and firm profitability as well as documenting the role of
financing factors (indebtedness, access to finance etc) (Lawless et al., 2020;
Gilchrist & Himmelberg, 1995; Whited, 1992). In particular, we control for
measures of firm performance and financial strength. For firm performance,
we use profit per employee (in thousands of euro) prior to the pandemic and
also the mean monthly wage. We also include a dummy variable for if the
firm is an exporter, which is typically associatedwith better performance. For
financial strength, we include ameasure of the firm’s internal resources (cash
or equivalents per employee) and its existing external debt commitments
(measures as the debt to asset ratio). We also include the response to a
question on whether the firm had intended to invest in 2020 prior to the
the outbreak of the pandemic. This variable should pick up performance
expectations as well as capture more difficult to observe willingness to take
risks.1
The key results are presented in Table 3. Possibly one of the most striking
features of the regression analysis is the extent towhich the expected standard
drivers of firm investment do not have any association with spending on
health compliance measures. Neither profit per employee of the debt to
asset ratio are statistically significant in any of the specifications. Cash per
employee is marginally significant in only one instance but even there the
effect is extremely small with each =C1000 in cash reserves linked to =C1.70 of
extra investment.
The characteristics (other than size and sector)most associatedwith higher
expenditure per employee are average wage and an expectation of investing
prior to the pandemic. The relationship with wages could be due to greater
need for specific types of equipment being required for specialised roles or
1 Summary statistics for these variables are available on request from the authors.
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settings or, more simply, a reflection of greater resources available in higher-
paying firms. Likewise, with a single cross-section of data, it is difficult
to disentangle the mechanisms that could be behind the effect of having
intended to invest in 2020 prior to the outbreak of the pandemic. Again,
this may be picking up an effect of available resources that could be shifted
from the existing planned investment to the new expenditure obligations
coming from the cost of health compliance measures. Alternatively, it could
be acting as a proxy for stronger firm growth expectations and management
characteristics.
As in the descriptive statistics discussed earlier, the differences across
firm size appear to come almost entirely from lower investments by the
self-employed with little direct evidence of differences across other firm
groups evident from the results in Table 3. This is slightly offset if the self-
employed firm expected to invest in 2020 as seen in the second columnwhere
interaction effects between size and investment expectations are included.
The sector effects (reported relative to the manufacturing sector) are in line
with our expectations from the descriptive statistics with considerable higher
expenditure in the most customer facing activities such as retail, hotels and
restaurants and human health.
4 Conclusions
This research has focused on a particular aspect of the impact of COVID-19
on enterprises, the expenditure on health compliance measures to ensure
the can operate safely and within public health guidelines. In the research,
we use a bespoke survey module to consider investment in health-related
measures by SMEs following the onset of the COVID-19 pandemic in Ireland.
This bespoke survey was designed to capture expenditure on public health
measures and we use it to explore the heterogeneity in expenditure across
firms and explore its determinants using traditional models. We find that
86 per cent of SMEs invested in health measures with a mean investment
of =C15,500 and a median of =C3,500, which equals to approximately =C500
(=C250) per employee. Nearly all investment was financed by internal funds.
Possibly one of the most striking features of the regression analysis is
the extent to which the expected standard drivers of firm investment do not
have any association with spending on health compliance measures. Neither
profit per employee of the debt to asset ratio are statistically significant in
any of the specifications. Cash per employee is marginally significant in only
one instance but even there the effect is extremely small with each =C1000 in
10
cash reserves linked to =C1.70 of extra investment. These findings lead us to
include that health investments are uncorrelatedwith economic performance
and financial factors, in contrast to traditional models. This highlights the
random nature of the COVID-19 shock. Major differences are evident across
sectors: the sector effects (reported relative to the manufacturing sector) are
in line with our expectations from the descriptive statistics with considerable
higher expenditure in the most customer facing activities such as retail,
hotels and restaurants and human health services. These results suggest
targetted policies addressing specific sectors are the most appropriate in
terms of providing support for effected firms. This should be born in mind
by policymakers when calibrating any remedial instruments.
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Table 3: Tobit regression
(1) (2) (3) (4) (5)
Baseline Interatctions All vars No FEs Only FEs
Profit per empl.∗ 0.431 0.442 0.418 0.169
(0.310) (0.309) (0.310) (0.310)
Mean monthly wage∗ 19.427* 20.119** 20.243** 9.545
(7.685) (7.790) (7.831) (7.672)
Cash per empl.∗ 1.673* 1.310 1.368 1.095
(0.807) (1.164) (1.167) (0.806)
Debt/Assets ratio 23.709 -16.714 -19.581 5.132



















Self-empl. -173.081** -230.786** -283.973** -231.071***





Agriculture -37.101 -34.908 -28.887 -98.414
(90.459) (91.046) (91.576) (86.269)
Construction 82.674 83.034 94.725 62.024
(66.287) (66.433) (70.927) (64.968)
Wholesale 46.518 46.298 50.035 29.712
(65.651) (65.989) (68.340) (60.893)
Retail 162.582** 164.779** 167.859* 105.954
(61.390) (61.775) (66.305) (59.976)
Motor trade 169.889* 162.504* 164.607* 176.743*
(78.379) (78.553) (83.174) (73.531)
Hotels & restaurant 302.359*** 305.003*** 312.834*** 184.005**
(67.640) (68.447) (74.650) (61.783)
Transport 10.636 13.314 14.920 20.315
(80.461) (81.105) (81.446) (78.567)
Real estate & finance 84.117 78.084 98.771 33.624
(92.840) (93.383) (99.276) (86.160)
Professional services -41.015 -43.721 -28.608 -88.644
(60.077) (60.542) (65.031) (61.036)
Admin. services 32.268 28.799 39.162 -7.641
(86.240) (85.521) (88.539) (81.027)
Human health 362.999*** 368.314*** 369.171*** 309.462***
(78.544) (79.508) (84.286) (69.141)
Constant 63.467 87.937 135.466* 226.921*** 263.234***
(55.397) (58.601) (67.281) (33.821) (47.428)
Var(Inv. per empl.) 2.6e+05*** 2.5e+05*** 2.5e+05*** 2.7e+05*** 2.6e+05***
(1.4e+04) (1.4e+04) (1.4e+04) (1.6e+04) (1.4e+04)
BIC 14698 14730 14755 14683 18828
Pseudo R2 0.008 0.009 0.009 0.004 0.003
N 1124 1124 1124 1124 1444
∗ in =C1000. Fixed effects relative to manufacturing sector. In column (3), size fixed effect relative to small
firms.
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Figure 4: Size distribution of COVID-19 measure investments
Dashed line = sector’s median, solid line = sector’s means.
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Figure 5: Sectoral distribution of COVID-19 measure investments
Dashed line = sector’s median, solid line = sector’s means.
